Clinical Trials Logo

Glaucoma clinical trials

View clinical trials related to Glaucoma.

Filter by:

NCT ID: NCT00466479 Completed - Glaucoma Clinical Trials

Brimonidine vs ALTP in Progressing Human Glaucoma

Start date: August 1999
Phase: Phase 4
Study type: Interventional

This study is evaluating possible non-intraocular pressure (IOP) related effects of the alpha-1 agonist brimonidine in human subjects affected by a progressive glaucomatous optic neuropathy. Brimonidine was proven as neuroprotective in several pre-clinical animal studies.

NCT ID: NCT00465803 Completed - Ocular Hypertension Clinical Trials

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Start date: March 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

NCT ID: NCT00465621 Completed - Ocular Hypertension Clinical Trials

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension

NCT ID: NCT00465348 Withdrawn - Clinical trials for Primary Open Angle Glaucoma

The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients

Start date: June 2009
Phase: N/A
Study type: Observational

To quantify oxidative stress in circulating leukocytes of normal tension glaucoma patients, prior to and one month after routine vascular therapy.

NCT ID: NCT00454922 Completed - Glaucoma Clinical Trials

Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients

Start date: October 2007
Phase: N/A
Study type: Interventional

Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication, which may result in loss of vision, is known to be prevalent. Available information regarding adherence to prescribed medical therapy suggests that some apparent treatment failures may actually be due to non-adherence. The investigators' specific aim is to conduct a study that will examine the effect of a glaucoma educator intervention on adherence to topical glaucoma therapy. The investigators' hypothesis is that patient education and counseling delivered by a trained glaucoma educator, through both planned visits and telephone contacts, will increase adherence to topical glaucoma therapy.

NCT ID: NCT00454025 Terminated - Glaucoma Clinical Trials

Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes

Start date: January 2007
Phase: N/A
Study type: Observational

Elevated intraocular pressure is widely accepted as a risk factor for glaucoma and controlling the pressure remains the cornerstone of effective treatment. There is evidence that posture can have a significant effect on intraocular pressure fluctuations. Salat (or Salah) refers to the five daily prayers performed by Muslims. The time spent praying in a kneeling or prostrate position may be associated with wide fluctuations in intraocular pressure, potentially sight-threatening for Muslim patients with glaucoma. The researchers seek to investigate the link between traditional daily Muslim prayer postural changes and intraocular pressure changes.

NCT ID: NCT00453024 Recruiting - Advanced Glaucoma Clinical Trials

Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures

Start date: February 2007
Phase: Phase 2
Study type: Interventional

When implanting an Ahmed glaucoma tube, a scleral flap is usually created to cover the tube, and the conjunctiva is stitched back in place with nylon 10-0 sutures. It is hypothesized that an equally safe or better method is using a bovine pericardial patch graft that can be secured in place over the tube with tissue glue, and using tissue glue to reposition the conjunctiva in place.

NCT ID: NCT00452998 Completed - Clinical trials for Chronic Angle Closure Glaucoma

Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study

Start date: November 2006
Phase: N/A
Study type: Interventional

Sequential Laser Iridotomy uses argon and Nd:yag laser in the first and second steps, respectively. Using q-switched 532 nm laser in the second step is hypothesized to be as good and effective as the conventional Nd:yag laser, because it selectively targets pigmented cells and delivers a short pulse duration of 3 nanoseconds, causing less thermal and collateral damage.

NCT ID: NCT00452283 Completed - Glaucoma Clinical Trials

Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy

Start date: March 2007
Phase: N/A
Study type: Observational

There is growing evidence that a cause of glaucoma is linked to circulatory problems and poor auto-regulation of blood flow to the optic nerve. Pulmonary hypertension (PH)is a disease characterized by low oxygen levels in the blood and altered blood circulation. The decrease in oxygen delivery to the optic nerve could lead to the loss of nerve fiber layer(NFL)in the retina and the resulting visual field compromise. This situation is characteristic of glaucoma. The ability to identify NFL thinning early could lead to earlier diagnosis of glaucoma and more effective treatment to limit dysfunction from visual field loss. We hypothesize that the rate of structural damage to the NFL, a feature of glaucoma, is higher in patients with PH than expected in healthy populations lacking this disease.

NCT ID: NCT00451152 Completed - Open-angle Glaucoma Clinical Trials

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.